Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyanoacrylate for Urethro-cutaneous Fistula Repair
NCT04876976Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of isoamyl 2-cyanoacrylate in urethrocutaneous fistula (UCF), sponsored by Ain Shams University. Primary endpoint: Successful repair of the fistula at 6 months. Started Jan 2017; status: completed.
02
Drugs
isoamyl 2-cyanoacrylate
03
Conditions
urethrocutaneous fistula (UCF)
Beyond the preview
Go deeper on NCT04876976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04876976.